Back

Osimertinib-induced heart failure.

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology 4 Cardio-Oncology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Beatriz Andrade

District Hospital of Santarem, Santarem (Portugal)

4 More presentations in this session

Presentation thumbnail
Pembrolizumab as a rare etiology of myocarditis
Mr M. De La Serna Real De Asua (Madrid, ES)
Slides Video
Presentation thumbnail
Complex cardiovascular manifestations after cancer treatment: a case of severe aortic and mitral stenosis with coronary artery disease
Doctor R. Fernandes (Coimbra, PT)
Slides Video
Presentation thumbnail
Primary cardiac diffuse large B-cell lymphoma: when the cause of heart failure is so massively unexpected
Doctor M. Martinho (Almada, PT)
Slides Video
Presentation thumbnail
A rare case of diffuse large B-cell lymphoma with cardiac involvement
Doctor I. Martins Moreira (Vila Real, PT)
Slides Video

Access the full session

Session thumbnail
Cardio-oncology 4

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
A UK multicentre experience of osimertinib related cardiovascular toxicity: real world patterns, risk stratification and surveillance
thumbnail
Congress Presentation
Bevacizumab-related cardiotoxicity in a 73-year-old breast cancer patient: a holistic management approach
thumbnail
Congress Presentation
Multidisciplinary approach in cardio-oncology: putting words into action

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources